Biobanks: Research allies. A new episode of Rare Horizons.
One of the greatest challenges in rare disease research is the limited availability of biological samples. We all know that studies based on small sample sizes often yield less conclusive results thanThe role of patient organisations in implementing newborn screening for rare diseases
A recent article published in the Rare Disease and Orphan Drugs Journal highlights the critical role of patient organisations in promoting newborn screening for rare diseases. The goal of these testsEarly screening can detect new paediatric tumours when there is a genetic predisposition
Thanks to recent advances in genomic sequencing, we have found out that 5-15% of children are genetically predisposed to developing a tumour. However, until now, it was not clear when to startLanguage discrimination in the access of children living with rare diseases to cross-border clinical trials in Europe
Language and country discrimination to access clinical trials have been identified as issues that violate children's rights in different regulatory environments. An EnprEMA working group is leading aSant Joan de Déu is developing a lab for studying living brain tissue from paediatric patients
Since 2014, the renowned neuroscientist Óscar Marín has been leading the Centre for Neurodevelopmental Disorders at King's College London, where he studies human brain development. He will direct thisFunding for the best collaborative research initiative: extension of the deadline for the Share4Rare Call4Projects
In response to inquiries and requests from those interested in this year's project call, Share4Rare will grant funding to the best collaborative research initiative based on data reported by patientsRare Horizons episode 2 focuses on people living without a diagnosis
People need to name things. Naming is our way of creating some order in this chaotic world. Unfortunately, many people are not able to name their disease. In Europe, it takes an average of five years